key: cord-0942617-zr086dww authors: Adachi, Takuya; Chong, Ja-Mun; Nakajima, Noriko; Sano, Masahiro; Yamazaki, Jun; Miyamoto, Ippei; Nishioka, Haruka; Akita, Hidetaka; Sato, Yuko; Kataoka, Michiyo; Katano, Harutaka; Tobiume, Minoru; Sekizuka, Tsuyoshi; Itokawa, Kentaro; Kuroda, Makoto; Suzuki, Tadaki title: Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan date: 2020-09-03 journal: Emerg Infect Dis DOI: 10.3201/eid2609.201353 sha: c1d84cdef2cc9e1047afe69b150b5c34f0170469 doc_id: 942617 cord_uid: zr086dww An autopsy of a patient in Japan with coronavirus disease indicated pneumonia lung pathology, manifested as diffuse alveolar damage. We detected severe acute respiratory syndrome coronavirus 2 antigen in alveolar epithelial cells and macrophages. Coronavirus disease is essentially a lower respiratory tract disease characterized by direct viral injury of alveolar epithelial cells. drug lopinavir/ritonavir was added orally. Despite all these treatment efforts, the dyspnea progressed and chest radiograph findings worsened (Figure 1 , panel D). Intravenous morphine was initiated to alleviate breathing difficulties from illness on day 14. The patient died from respiratory failure on February 20 (illness day 16). The patient's family gave consent for an autopsy to be performed. An autopsy was conducted 5 hours after death, with the exception of the brain and bone marrow. Macroscopically, the trachea and bronchi exhibited neither redness nor erosion; however, the lungs (left, 590 g; right, 690 g) were partially dark red, consolidated, and airless. The cut surface was slightly sticky. Specifically, both pleurae were slightly thickened, with pleural effusions of <1 mL in each pleural cavity. The heart (420 g) showed right ventricular dilatation, with 10 mL of cardiac effusion. We noted diffuse multiple punctate hemorrhages in the mucosa of the stomach and duodenum. Histologic analysis revealed that the lungs exhibited features of both exudative and organizing diffuse alveolar damage (DAD). The lung tissues in the exudative phase of DAD showed prominent hyaline membranes (Figure 2 , panel A), and those in the organizing phase of DAD showed desquamation, squamous metaplasia of the epithelial cells ( Figure 2 , panel B), organizing hyaline membranes ( Figure 2 , panel C), and inflammatory cell infiltration with prominent plasma cells in the alveolar septa ( Figure 2 , panel D). We observed intra-alveolar hemorrhage, vascular congestion, and hyperplasia of type 2 pneumocytes. We also noted multinucleated syncytial cells. In addition, we detected hemophagocytosis in the lungs, spleen, and lymph nodes ( Figure 2 , panel E). The glomeruli of both kidneys were marked by microthrombi, suggesting early signs of disseminated intravascular coagulation (Figure 2 , panel F). We observed no notable changes in the other organs. To examine the distribution of SARS-CoV-2 antigens, we performed immunohistochemistry on all tissue sections by using rabbit polyclonal antibodies against the SARS-CoV nucleocapsid protein (8) . We confirmed the reactivity of the antibody by using SARS-CoV-2-infected VeroE6/TMPRSS2 cells as a positive control and a mock-infected VeroE6/ TMPRSS2 cells as a negative control (9) . We detected SARS-CoV-2 antigens in the cytoplasm of alveolar epithelial cells in earlier-stage DAD lesions, with mild inflammation before formation of hyaline membranes ( Figure 2 , panel G) rather than progressed lesions. We also detected viral antigens detected in the cytoplasm of multinucleated syncytial cells ( Figure 2 , panel G, inset). We detected no signals in the trachea, intestine, or other extrapulmonary tissue sections. Double immunofluorescence staining revealed that the viral antigen was present in epithelial membrane antigen-positive alveolar epithelial cells and CD68 (clone PGM-1)-positive alveolar macrophages (Figure 2 , panels H and I). We determined copy numbers of SARS-CoV-2 RNA in various specimens by using real-time reverse transcription PCR to amplify a segment in the nucleocapsid protein-encoding region of SARS-CoV-2 RNA, using forward (5¢-GGCCGCAAATTGCACAAT-3¢) and reverse (5¢-CCAATGCGCGACATTCC-3¢) primers, and a labeled probe 5¢-(FAM)-CCCCCAGCGCTTCAGC-GTTCT-(TAMRA)-3¢ (Table 2) . We collected postmortem tissues by using a new set of forceps and scissors for each sample to avoid cross-contamination. We used the amount of human glyceraldehyde-3-phosphate dehydrogenase mRNA in the RNA extracted from each tissue as an internal reference for normalization. Although SARS-CoV-2 RNA loads in serum samples increased from illness day 8 to day 13, at the time of autopsy, we detected SARS-CoV-2 RNA at low levels in whole blood and feces but not in urine. The copy numbers of SARS-CoV-2 RNA detected in the swab samples collected during the autopsy were higher in the right bronchus than in the nasopharynx. In addition, SARS-CoV-2 RNA glyceraldehyde-3-phosphate dehydrogenase mRNA ratios in each tissue sample showed that viral loads in peripheral lung tissues were higher than those in trachea, bronchi, and upper respiratory tract tissues. We also detected low levels of SARS-CoV-2 RNA in nonrespiratory tract tissues, including the colon, liver, and spleen. Whole-genome sequencing of SARS-CoV-2 from the lung of the patient did not indicate substantial mutations except for a few singlenucleotide variations, including G11083T transversion compared with Wuhan-Hu-1 (GenBank accession no. MN908947; GISAID identification no. EPIISL402125), which is shared by the isolates obtained from the Diamond Princess cruise ship outbreak. We report an autopsy of an 84-year-old cruise ship passenger who died from COVID-19. Lung pathology showed exudative and organizing phases of DAD, similar to what is observed in cases of severe acute respiratory syndrome (10) (11) (12) (13) . We detected SARS-CoV-2 antigen in alveolar epithelial cells and alveolar macrophages, also similar to what is observed in cases of severe acute respiratory syndrome (14, 15) . COVID-19 begins with upper respiratory tract symptoms (3) and ultimately becomes a lower respiratory tract disease in the later stages, based on the higher copy numbers of SARS-CoV-2 in the lower respiratory tract, relative to serum, whole blood, urine, feces, and rectal swab specimens taken during the clinical course and after death. COVID-19 is probably caused by direct injury of alveolar epithelial cells by SARS-CoV-2, accompanied by secondary damage to nonrespiratory organs. The high prevalence of SARS-CoV-2 infection on the cruise ship could not be attributed to specific genetic mutations of the virus. Our deepest condolences go to the family of the patient, who was a caring mother and grandmother, and for whom a cruise ship vacation was a lifetime dream. We thank the patient's family, who generously offered us an opportunity to explore the pathology of this unknown disease, despite their grief at the loss of their family member. We also thank our nursing team at Toshima Naming the coronavirus disease (COVID-19) and the virus that causes it World Health Organization. Coronavirus disease 2019 (COVID-19) situation report 67 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Pathological findings of COVID-19 associated with acute respiratory distress syndrome Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer Press release: current situation of the novel coronavirus infection Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells The clinical pathology of severe acute respiratory syndrome (SARS): a report from Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore Pulmonary pathology of severe acute respiratory syndrome in Toronto Pathology and pathogenesis of severe acute respiratory syndrome SARS coronavirus-infected cells in lung detected by new in situ hybridization technique Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS Dr. Adachi is the chief of the Department of Infectious Diseases at Toshima Hospital. His primary research interests include clinical management in an outbreak. He has been part of international outbreak response teams for Ebola disease, yellow fever, diphtheria, and cholera.